A previously healthy woman aged 74 noticed swollen ankles and was admitted to hospital 24 hours later. She was found to have nephrotic syndrome with proteinuria 18.4 g/24 h and renal impairment (serum urea 15.4 mmol/L, creatinine 231 mmol/L). Other laboratory results included total protein 43 g/L, albumin 18 g/L, creatinine clearance 20 mL/min, total cholesterol 11.94 mmol/L, triglycerides 4.44 mmol/L, potassium 2.8 mmol/L, thyroid stimulating hormone 19.4 mU/L, free thyroxin 6.9 pmol/L, antinuclear factor negative, complements C3 and C4 within normal range. Bence Jones protein was not found in urine, nor were paraproteins detected on serum protein electrophoresis. On abdominal sonography the kidneys were of normal size, and an incidental ®nding was a 4 cm mass in the right lobe of the liver. Rather than undergo liver biopsy at that stage, the patient opted to have a repeat scan later. A renal biopsy specimen showed normal glomeruli with no segmental sclerosis and no immune complex deposition, consistent with minimal change disease. Steroids were given at the dose of 1 mg/kg per day, initially intravenously (methylprednisolone) and subsequently orally (prednisolone). Her additional therapy included ranitidine, atorvastatin, thyroxin, amphotericin B, amiloride, bendro¯uazide and ramipril. After a week the oedema began to subside and she lost 10 kg in body weight. Gradually the serum albumin increased and, after 4 weeks, proteinuria was absent, serum albumin had risen to 37 g/L, and serum cholesterol and triglycerides were normal. Steroids were discontinued after three months and she remained free from proteinuria.
A second abdominal ultrasound, undertaken a month later, showed multiple small nodules in the liver suggestive of metastatic disease and a liver biopsy specimen contained metastatic poorly differentiated adenocarcinoma. On mammography there was a mass in the medial part of the right breast 13 mm in diameter which proved to be a primary breast adenocarcinoma. The patient was treated with tamoxifen, with little response, and died six months later.
COMMENT
The close association between solid organ tumour and minimal change nephropathy implies, but does not prove, causality. In most reports the tumour is renal cell carcinoma 1±5 . Others that have been linked with minimalchange nephropathy are adenocarcinoma of the colon 6,7 , small-cell lung carcinoma 8 and pancreatic adenocarcinoma metastatic to the liver 9 . An association with breast cancer (with lymph node and bone metastases) has been reported once 8 . In some cases the nephrotic syndrome remitted completely after surgery for carcinoma 2, 6, 9 . Although the association of carcinoma with minimal change disease is rare, it should be borne in mind particularly in older patients.
